SynthesisFrontiers in medicine2021
Systematic Review of the Effect of a Zero-Markup Policy for Essential Drugs on Healthcare Costs and Utilization in China, 2015-2021.
Synthesis in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Health and health system impacts of China's comprehensive primary healthcare reforms: a systematic review.Health policy and planning · 2023Pooled it
- The price and affordability of essential medicines, progress and regional distribution in China: a systematic review.Frontiers in pharmacology · 2023Pooled it
- Workload and personnel allocation in pharmacy departments of public hospitals in China: a current state study.Scientific reports · 2026Article
- Evaluating the Zero-Markup Drug Policy's Effects on Financial Burden and Pharmaceutical Channel Migration: A Structural Variation and Interrupted Time Series Analysis from Hubei, China.Journal of healthcare leadership · 2026Article
- Article
- Factors contributing to hospitalization expenditures for patients with COPD in Yunnan Province, China: a path analysis.BMC health services research · 2024Article
- Technical efficiency and its convergence among village clinics in rural China: evidence from Shanxi Province.Frontiers in public health · 2024Article
- Differential effect of China's Zero Markup Drug Policy on provider-induced demand in secondary and tertiary hospitals.Frontiers in public health · 2024Article
- Antibiotic Culture: A History of Antibiotic Use in the Second Half of the 20th and Early 21st Century in the People's Republic of China.Antibiotics (Basel, Switzerland) · 2023Article
- Inpatient costs of congenital heart surgery in China: results from the National Centre for Cardiovascular Diseases.The Lancet regional health. Western Pacific · 2023Article
- How Can China's New Health Care Reform Promote the Balance of Interest Game?-Based on Game Evolution and Simulation Analysis.Risk management and healthcare policy · 2023Article
- Medications and medical costs for diabetes patients with or without chronic respiratory disease in Beijing, China: A retrospective study.Frontiers in endocrinology · 2022Observational
- Weighing patient attributes in antibiotic prescribing for upper respiratory tract infections: A discrete choice experiment on primary care physicians in Hubei Province, China.Frontiers in public health · 2022Article
- Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China.BMC health services research · 2021Article
- Healthcare Professionals' Views of the Integrated County Healthcare Consortium in Zhejiang, China.International journal of integrated careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.